ASH 2010 Conference Coverage

Comorbid conditions associated with worse lung cancer survival

Lung cancer patients with comorbid conditions, such as chronic obstructive pulmonary disease or diabetes, had a greater risk of death than lung cancer patients without these conditions.

Benefits found for screening colonoscopies of higher quality

Higher adenoma detection rates may be associated with much lower lifetime colorectal cancer incidence and death without higher overall costs, research indicates.

High-grade cervical lesions declining in young women

A decrease in cervical lesions among young women in the United States has been observed, but the cause for this drop is not proven.

Early relapse of follicular lymphoma may increase risk of death

Early relapse of follicular lymphoma could be carefully considered when making decisions about treatment for these patients.

Study identifies perception gap in incidence, impact of CINV/RINV

There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of CINV/RINV.

Survival in adult patients with low-grade brain tumors has improved

Outcomes for patients with low-grade gliomas have improved significantly in recent years, according to an analysis of clinical data collected from a US cancer registry over the past decade.

Blood antibodies may predict survival of HPV-positive oropharyngeal cancer

The presence of certain human papillomavirus (HPV)-16 antibodies in the blood is associated with improved survival rates for patients with HPV-related oropharyngeal carcinoma.

Avocados may hold the answer to beating leukemia

Can molecules derived from avocados be used as a tool to combat leukemia?

Obesity associated with increased breast cancer risk in postmenopausal women

Clinical trial data suggests that postmenopausal women of above-average weight have an increased risk of breast cancer.

Managing oral oncology/hematology treatments in your practice

An increasing number of oncology/hematology treatments will consist of oral oncolytics, and oncology programs are needed to manage the treatment of patients following these regimens.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs